PEDS Advance Access published online on January 11, 2007
Protein Engineering Design and Selection, doi:10.1093/protein/gzl047
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bacteriophage Mu C protein is a new member of unusual leucine zipper-HTH class of proteins
1 Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560 012, India 2 Laboratory of Gene Regulation and Development, National Institute of Child Health and Human Development, National Institute of Health, Bethesda, MD 20892, USA 3 Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore 560 064, India
4 To whom correspondence should be addressed. E-mail: vraj{at}mcbl.iisc.ernet.in
| Abstract |
|---|
|
|
|---|
Transcription activator protein C of bacteriophage Mu activates transcription of the late genes, including mom, during the lytic cycle of the phage. C binding to its site leads to the alteration in DNA topology of the promoter elements resulting in RNA polymerase (RNAP) recruitment. At the next step, the transactivator enhances promoter clearance of RNAP from Pmom. The C protein binds DNA with a very high affinity using a carboxyl-terminal helix turn helix (HTH) motif which has similarity with the HTH from paired domain of Drosophila prd protein. Previous studies established that the protein is dimeric in free and DNA bound forms. We describe now the unique dimerization interface of the protein. Two heptad repeats of hydrophobic amino acids found in the protein were considered to be the candidates for dimerization region. Site-directed mutational analysis revealed that the amino-terminal coiled coil region is not the dimerization determinant. In contrast, similar mutagenesis studies indicated a role for the leucine zipper motif, located in the middle region of the protein, in dimerization. Mixed oligomerization assays confirmed the importance of leucine zipper in C dimer formation establishing the presence of an uncommon zipper-HTH domain in the transactivator.
Keywords: C protein/helix turn helix/leucine zipper/phage Mu/transcription activation
| Introduction |
|---|
|
|
|---|
The mom gene of bacteriophage Mu is unique in terms of the biochemical activity of its product and the regulation of expression (Kahmann and Hattman, 1987
C binds to its cognate site next to 35 element at Pmom as a dimer with very high affinity. Mutagenesis and homology modeling demonstrated that an extended helix turn helix (HTH) motif, consisting of a three-helix bundle preceded by a ß turn, is responsible for DNA binding (Paul et al., 2003
). The analysis of the primary sequence of the protein revealed the presence of two putative hydrophobic repeat sequences as candidates for dimerization motif. Mutagenesis and chemical crosslinking studies ruled out the N-terminal heptad repeat to be involved in dimerization and suggested the second leucine zipper like motif as dimerization domain. We have characterized the dimerization interface of C further and show that C is a new member of the emerging family of bacterial dimeric DNA-binding proteins containing both HTH and leucine zipper.
| Materials and methods |
|---|
|
|
|---|
Bacterial strains and plasmids
Escherichia coli DH10B was used for cloning experiments. The expression strain E. coli BL26 (DE3) was obtained from Novagen (Madison, WI, USA). The plasmid pVR7 (Ramesh et al., 1994
), carrying C gene under the control of the T7 gene
10 promoter was used both for expression of C protein and site-directed mutagenesis.
Mutagenesis and preparation of mutant proteins
Site-directed mutagenesis was carried out using the GeneEditorTM in vitro mutagenesis kit (Promega, Madison, WI, USA). The minimal heptad repeat (M44-Y92) was amplified with basic leucine zipper (bZip) forward and reverse primers using pVR7 as template. The PCR product was cloned into NcoI and blunted BamHI sites of pET11d (Novagen) vector to obtain the minimal zipper polypeptide. Mutants were confirmed by sequencing the obtained clones. The E. coli BL26 (DE3) cells, harboring plasmids expressing wild-type (wt) or mutant C protein, were grown in LB containing 100 µg/ml ampicillin up to an OD of 0.6 at A600 and induced with 0.3 mM IPTG for 3 h at 37°C. After harvesting, cells were suspended in buffer containing 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 1 mM EDTA, 7 mM 2-mercaptoethanol, 5% glycerol, 100 mM NaCl and 1 mM PMSF and disrupted by sonication. The extract was centrifuged at 20 000g for 30 min at 4°C (S20 fraction). All the mutant proteins were present in the insoluble S20 pellet fractions. The pellet fractions were resolved in 15% SDS-PAGE and visualized by negative staining using CuCl2. The bands corresponding to the overexpressed proteins were excised and eluted from SDS polyacrylamide gel using a BioRad electroelutor. The eluted proteins were then subjected to acetone precipitation to remove SDS, denatured in refolding buffer (10 mM HEPES pH 7.4, 5 mM MgCl2, 1 mM EDTA, 100 mM NaCl and 5% glycerol) containing 6 M urea and then renatured by stepwise dialysis against refolding buffer containing 4, 2 and 1 M urea, respectively. The proteins were then dialysed against the same buffer lacking urea.
Electrophoretic mobility shift assay
Five picomoles of the top strand of a 25 mer C-binding site with the sequence 5'-AGATCGATTATGCCCCAATAACCAC-3' was labeled using 40 µCi of [
32P]ATP (6000 Ci/mmol, PerkinElmer) and mixed with 2.5-fold molar excess of the complementary strand and incubated for 5 min at 85°C. The mixture was allowed to cool slowly to room temperature following which the DNA was purified by passing through Sephadex G50.
The assays were carried out as described previously (Ramesh and Nagaraja, 1996
), in 20 µl reactions in binding buffer (20 mM Tris-HCl pH 8.0, 5 mM MgCl2, 1 mM EDTA, 7 mM 2-mercaptoethanol, 5% glycerol and 100 mM NaCl). DNA (10 000 cpm) was incubated with 100 ng of wt C protein or 1 µg of mutant proteins on ice for 15 min. The reactions were applied on a 10% native polyacrylamide gel and electrophoresed in 0.5 x TBE (45 mM Tris-borate, 1 mM EDTA pH 8.0) buffer at 150 V for 1 h at 4°C and subjected to autoradiography.
The ability of the C protein and the mutant proteins to form dimers was assessed by chemical crosslinking using glutaraldehyde (Merck) as described previously (Ramesh and Nagaraja, 1996
). All the proteins under study were denatured in 6 M urea and sequentially renatured as described in the preceding section. Purified C or its mutants were dialyzed against crosslinking buffer (10 mM HEPES pH 7.4, 5 mM MgCl2 pH 7.5, 1 mM EDTA, 100 mM NaCl, 7 mM 2-mercaptoethanol, 5% glycerol). C or mutant proteins (1 µg) were incubated with different concentrations of glutaraldehyde (0.0025 and 0.005%) at room temperature for 30 min. The reactions were stopped by the addition of SDS loading dye, subjected to 15% SDS-PAGE and visualized by silver staining. For mixed oligomerization assay, 1 µg C was mixed with 2 µg of minimal zipper polypeptide and incubated for 10 min in ice. Glutaraldehyde was added to a final concentration of 0.005% and the crosslinking was allowed for 15 min at room temperature. Reactions were stopped by the addition of SDS loading dye, analysed on 15% tricine SDS PAGE and visualized by silver staining.
| Results and discussion |
|---|
|
|
|---|
Primary sequence analysis of C protein
Transactivator C is a 16.5 kDa protein containing 140 amino acids. The protein is a dimer in solution and binds DNA in the dimeric form (De et al., 1997
). Within the short protein, the HTH motif located towards the carboxy terminal is involved in DNA binding (Paul et al., 2003
). The protein contains two putative dimerization motifs as shown in Fig. 1. Towards the N-terminal region, a putative coiled coil motif was identified by analysing the primary sequence with COILS program (Lupas et al., 1991
). Coiled coil is characterized by the presence of hydrophobic residues in every first and fourth position in each heptad repeat. A 14 amino acid stretch (V35R48) showed the probability of forming coiled coil where first and fourth amino acids are hydrophobic that could form hydrophobic interface for homodimerization. In the middle part of the protein, a putative leucine zipper motif (V63L90) is also found. In a typical leucine zipper, every seventh amino acid is an L or an I. As represented by a helical wheel, four continuous heptad repeats in C protein contain L or I at the seventh position (Fig. 2). Both of the candidate regions were subjected to further analysis to determine the dimerization interface of C protein.
|
|
Characterization of the motifs in C protein
The amino-terminal coiled coil region has been analysed by site-directed mutagenesis. To disrupt the region, hydrophobic residues V or L were mutated to charged amino acid R. In spite of the non-conservative changes involving bulky replacements in the region, the mutants were efficient in dimerization as observed by glutaraldehyde crosslinking (Table I), indicating that the putative coiled coil region is not important for dimerization of the protein. In order to disrupt the putative leucine zipper, the repeated L residues were mutated individually by site-directed mutagenesis. They were substituted with M, R or S. All the single mutants of leucine zipper were efficient in dimerization as observed by glutaraldehyde crosslinking (Table I). They were also proficient in DNA binding indicating that dimerization is not significantly affected. However, a double mutant, L83RL90S, showed highly compromised dimerization. It has been observed in case of many leucine-zipper-containing proteins, viz. GCN4 homodimer (van Heeckeren et al., 1992
), Fos-Jun heterodimer (Kouzarides and Ziff, 1988), MetR homodimer (Maxon et al., 1990
), that dimerization could not be effectively disrupted by a single mutation. Mutations in two conserved leucines were required in order to disrupt the leucine-zipper-mediated proteinprotein interaction. The minimal leucine zipper polypeptide (minimal LZ, comprising residues 44 to 92 of the C protein, as shown in Fig. 3A), when tested, showed efficient crosslinking, indicating that the leucine zipper is responsible for dimerization (Table I).
|
|
In order to confirm the role for the leucine zipper in dimerization, we carried out a mixed oligomerization assay with full-length C protein and the minimal LZ (Fig. 3A) according to the strategy depicted in Fig. 3B. In this assay, full-length C would form homodimer upon crosslinking. If the minimal LZ possesses the dimerization domain, it would form a homodimer. When both the proteins are present, the minimal LZ would compete with the full-length C and form a heterodimeric species. The size difference between the two proteins facilitates the separation of the three crosslinked species viz. C homodimer, minimal LZ homodimer and C-minimal LZ heterodimer, on a denaturing PAGE. The result of such mixed oligomerization assay is presented in Fig 3C. C protein showed dimerization upon crosslinking (Fig. 3C, lane 2). The minimal LZ also formed dimer under these assay conditions (Fig. 3C, lane 4). C protein (1 µg) was mixed with 2 µg of minimal LZ and subjected to glutaraldehyde crosslinking. In addition to C dimer and minimal LZ dimer, there was an additional crosslinked product with lower mobility than C monomer (Fig. 3C, lane 5). The product is the crosslinked species of C and minimal LZ. These results demonstrate that the leucine zipper region not only forms homodimer, it can also compete with full-length C to form a heterodimer, assigning a role for the leucine zipper in C dimer formation.
The leucine zipper does not participate in DNA binding by C protein
Presence of a stretch of basic amino acids preceding the leucine zipper in C protein prompted us to analyse the possible connection between leucine zipper and DNA binding. Eukaryotic bZIP motifs, which are responsible for dimerization and DNA binding, contain two conserved residues in the basic stretch, C and N, at 11 and 18 positions from the first L in the zipper (Lau et al., 1997
). The basic amino acid stretch in C protein does not contain the conserved C or N residues, suggesting that in this case the leucine zipper possibly does not influence DNA binding of the protein. Nevertheless, the DNA-binding efficiency of the dimerization-deficient double mutant of C, L83RL90S, and the minimal LZ was analysed using electrophoretic mobility shift assay (EMSA). The double mutant did not bind to the DNA, as the mutant is unable to dimerize (Fig. 4). The dimerization-efficient minimal LZ, containing the basic stretch, also did not bind to the DNA in EMSA, indicating that the basic stretch preceding the zipper is not contributing to DNA binding and the motif is not a typical bZIP motif (Fig. 4). Also, the DNA-binding mutants of C viz. L103Q and I114N that are part of the HTH motif, where zipper region is unaltered, did not show compromised dimerization. These results demonstrate that the HTH and the leucine zipper motifs are modular and dimerization activity of the leucine zipper is not affected by the HTH motif. The leucine zipper motif does not participate in DNA binding directly but influences indirectly as only dimeric C binds to the DNA.
|
A majority of the transcription activators bind to the DNA as dimers and use a variety of dimerization domains e.g. helix loop helix (HLH), leucine zipper, coiled coil etc. The present work demonstrates that C protein of phage Mu dimerizes through a leucine zipper motif, an uncommon oligomerization motif for a bacterial transcription activator. Leucine zipper motif was originally identified in eukaryotic transcription activators GCN4, cMyc, Fos, Jun and C/EBP (Landschulz et al., 1988
|
C protein is thus a new member of emerging group of regulatory proteins that contain both HTH and zipper motifs. Although C appears to share the similar motif with the other members of zipper-HTH family of proteins, it does not exhibit any sequence similarities with them indicating its distant origin. The DNA-binding domain of C is unusual in that it has a striking similarity with the paired domain of Drosophila prd protein (Paul et al., 2003
| Acknowledgements |
|---|
|
|
|---|
A.C. is a recipient of senior research fellowship of Council of Scientific and Industrial Research, India. The work has been supported by a grant from Department of Science and Technology, Government of India to V.N.
| References |
|---|
|
|
|---|
Balke V., Nagaraja V., Gindlesperger T., Hattman S. (1992) Nucleic Acids Res. 20:27772784.
Basak S. and Nagaraja V. (1998) J. Mol. Biol. 284:893902.[CrossRef][Web of Science][Medline]
Beloin C., McKenna S., Dorman C.J. (2002) J. Biol. Chem. 277:1533315344.
Blackwood E.M. and Eisenman R.N. (1991) Science 251:12111217.
Chakerian A.E., Tesmer V.M., Manly S.P., Brackett J.K., Lynch M.J., Hoh J.T., Matthews K.S. (1991) J. Biol. Chem. 266:13711374.
Chakraborty A. and Nagaraja V. (2006) J. Biol. Chem. 281:85118517.
De A., Paul B.D., Ramesh V., Nagaraja V. (1997) Protein Eng. 10:935941.
Ferre-D'Amare A.R., Prendergast G.C., Ziff E.B., Burley S.K. (1993) Nature, (London) 363:3845.[CrossRef][Medline]
Garcia de Viedma D., Serrano-Lopez A., Díaz-Orejas R. (1995) Nucleic Acids Res. 23:50485054.
Giraldo R., Nieto C., Fernandez-Tresguerres M.E., Diaz R. (1989) Nature (London) 342:866.[Medline]
Giraldo R. and Fernandez-Tresguerres M.E. (2004) Plasmid 52:6983.[CrossRef][Web of Science][Medline]
Hattman S. (1999) Pharmacol. Ther. 84:367388.[CrossRef][Web of Science][Medline]
Johnson P.F. and McKnight L.S. (1989) Annu. Rev. Biochem. 58:799839.[CrossRef][Web of Science][Medline]
Jones N. (1990) Cell 61:911.[CrossRef][Web of Science][Medline]
Kadesch T. (1993) Cell Growth Differ. 4:4955.[Web of Science][Medline]
Kahmann R. and Hattman S. (1987) In Symonds N., Toussiant A., van de Putte P., Howe M.M. (Eds.). Phage Mu.(Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 93109.
Kaptein R., Zuiderweg E.R.P., Scheek R.M., Boelens R., van Gunsteren W.F. (1985) J. Mol. Biol. 182:179182.[CrossRef][Web of Science][Medline]
Kouzarides T. and Ziff E. (1988) Nature 336:646651.[CrossRef][Medline]
Lau C.K.P., Wang Y., Patel A., Labbe D., Bergeron H., Brousseau R., Konishi Y., Rawlings M. (1997) Proc. Natl Acad. Sci. USA 94:14531458.
Landschulz W.H., Johnson P.F., McKnight S.L. (1988) Science 240:17591764.
Lupas A., Van Dyke M., Stock J. (1991) Science 252:11621164.
Maxon M.E., Wigboldus J., Brot N., Weissbach H. (1990) Proc. Natl Acad. Sci., USA 87:70767079.
Murre C. and Baltimore D. (1992) In McKnight S.L. and Yamamoto Y.R. (Eds.). Transcriptional Regulation(Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) pp. 861.
Paul B.D., Kanhere A., Chakraborty A., Bansal M., Nagaraja V. (2003) Proteins 52:272282.[CrossRef][Web of Science][Medline]
Ramesh V. and Nagaraja V. (1996) J. Mol. Biol. 260:2233.[CrossRef][Web of Science][Medline]
Ramesh V., De A., Nagaraja V. (1994) Protein Eng. 7:10531057.
Sun W. and Hattman S. (1998) J. Mol. Biol. 284:885892.[CrossRef][Web of Science][Medline]
van Heeckeren W.J., Sellers J.W., Struhl K. (1992) Nucleic Acids Res. 20:37213724.
Weber I.T., McKay D.B., Steitz T.A. (1982) Nucleic Acids Res. 10:50855102.
Received June 28, 2006; revised September 24, 2006; accepted October 3, 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



